I am not sure why people discuss the strategy for China.
The strategy has been clearly outlined in the announcement. It is a similar approach as the one in Australia. The product is to be sold through pharmacy channels.
I am sure there will also be some online pharmacies among them. The e-pharmacy market was worth almost A$6 billion in 2016 with whopping YOY increases. It almost doubled from 2015 to 2016, with further increases to happen.
(Source: http://daxueconsulting.com/e-pharmacy-in-china/)
I wonder if AliHealth/CVS is among the pharmacy channels...
http://www.chinadaily.com.cn/china/2017-09/13/content_32195200.htm
I am not sure why people discuss the strategy for China. The...
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
-0.001(11.1%) |
Mkt cap ! $3.691M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.9¢ | 0.8¢ | $8.671K | 1.051M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1735002 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 340000 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |